Stay updated with breaking news from Merck Sharp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TME PHARMA RECEIVES US FDA FAST TRACK DESIGNATION FOR LEAD ASSET NOX-A12 IN BRAIN CANCER Fast Track designation awarded by the...
TME PHARMA RECEIVES US FDA FAST TRACK DESIGNATION FOR LEAD ASSET NOX-A12 IN BRAIN CANCER Fast Track designation awarded by the...
Fast Track designation awarded by the FDA serves as an external validation of the potential of NOX-A12 for unmet need in glioblastoma and could support an accelerated pathway to US regulatory...
- Data for masked anti-CTLA-4 SAFEbody® ADG126 highlight best-in-class therapeutic index and demonstrate clinical benefits in metastatic microsatellite-stable colorectal cancer with higher, more...
Harpoon Therapeutics (NASDAQ:HARP – Get Free Report) and LianBio (NASDAQ:LIAN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation. Profitability This table compares Harpoon Therapeutics and LianBio’s […]